ResearcherUniversity of MinnesotaNo recent work listed

Guillaume C. Onyeaghala

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8090-5640; OpenAlex author ID A5055566406. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 1 paper

Papers 2

Association between MICA polymorphisms, s-MICA levels, and pancreatic cancer risk in a population-based case-control study. Co-author DOI 10.1371/journal.pone.0217868 ↗
Soluble MICA is elevated in pancreatic cancer: Results from a population based case-control study. Co-author DOI 10.1002/mc.22667 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kristin E. Anderson · 2 shared papers, 2017–2019 · strength 0.17
- Paper Association between MICA polymorphisms, s-MICA levels, and pancreatic cancer risk in a population-based case-control st… DOI 10.1371/journal.pone.0217868 ↗
- Paper Soluble MICA is elevated in pancreatic cancer: Results from a population based case-control study. DOI 10.1002/mc.22667 ↗
Anna E. Prizment · 2 shared papers, 2017–2019 · strength 0.17
- Paper Association between MICA polymorphisms, s-MICA levels, and pancreatic cancer risk in a population-based case-control st… DOI 10.1371/journal.pone.0217868 ↗
- Paper Soluble MICA is elevated in pancreatic cancer: Results from a population based case-control study. DOI 10.1002/mc.22667 ↗
Myron D. Gross · 1 shared paper, 2017 · strength 0.07
- Paper Soluble MICA is elevated in pancreatic cancer: Results from a population based case-control study. DOI 10.1002/mc.22667 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.